{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:35:33Z","timestamp":1793039733528,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2016827"],"award-info":[{"award-number":["GNT2016827"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.antiviral.2026.106510","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:37:30Z","timestamp":1786981050000},"page":"106510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antiviral profile of hepatitis B virus capsid assembly modulator ALG-001075, the parent of pevifoscorvir sodium"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-9408","authenticated-orcid":false,"given":"Yannick","family":"Debing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6295-0781","authenticated-orcid":false,"given":"Hannah","family":"Vanrusselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4439-3377","authenticated-orcid":false,"given":"Jordi","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-6082","authenticated-orcid":false,"given":"Lars","family":"Degrauwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9 Buh","family":"Kum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Acosta","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilson Carlos","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-5448","authenticated-orcid":false,"given":"Emma","family":"Wanicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Netter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-2738","authenticated-orcid":false,"given":"Paul A.","family":"Ramsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabih","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Deval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4489-340X","authenticated-orcid":false,"given":"Michael","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Serebryany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antitsa","family":"Stoycheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Beigelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Raboisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Vendeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-I","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence M.","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Lecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-2622","authenticated-orcid":false,"given":"Andreas","family":"Jekle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106510_bib1","series-title":"Dosing with the Capsid Assembly Modulator ALG-000184 in Untreated Hbeag Negative CHB Subjects Results in Potent Antiviral Effects Including Suppression of HBV DNA\/RNA and Declines in Hbcrag Levels","author":"Agarwal","year":"2024"},{"key":"10.1016\/j.antiviral.2026.106510_bib3","first-page":"e01701","article-title":"Novel hepatitis B virus capsid assembly modulator induces potent antiviral responses in vitro and in humanized mice","volume":"64","author":"Amblard","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115952","article-title":"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents","volume":"31","author":"Amblard","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106510_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00560-17","article-title":"Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus","volume":"61","author":"Berke","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01502-23","article-title":"Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation","volume":"98","author":"Berke","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106510_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep43160","article-title":"Yield optimisation of hepatitis B virus core particles in E. coli expression system for drug delivery applications","volume":"7","author":"Bin Mohamed Suffian","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106510_bib8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bi801814y","article-title":"A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly","volume":"48","author":"Bourne","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2026.106510_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262516","article-title":"Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy","volume":"17","author":"Burdette","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106510_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2018.07.011","article-title":"Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro","volume":"158","author":"Corcuera","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106510_bib11","series-title":"Preclinical Assessment of a Novel Capsid Assembly Modulator, ALG-001075, Demonstrates best-in-class in Vitro Potency and in Vivo Antiviral Efficacy","author":"Debing","year":"2019"},{"key":"10.1016\/j.antiviral.2026.106510_bib12","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/AAC.46.9.3057-3060.2002","article-title":"Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro","volume":"46","author":"Delaney","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106510_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/13596535251392955","article-title":"A phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel class E capsid assembly modulator, in healthy participants","volume":"30","author":"Gane","year":"2025","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2026.106510_bib16","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2026.106510_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/v13010114","article-title":"Studies on the efficacy, potential cardiotoxicity and monkey pharmacokinetics of GLP-26 as a potent hepatitis B virus capsid assembly modulator","volume":"13","author":"Hurwitz","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106510_bib18","series-title":"Viral Kinetics and Sequence Analysis of a Phase I Monotherapy Study in Subjects with Chronic Hepatitis B Reveals a High Barrier of Resistance to the Capsid Assembly Modulator ALG-000184","author":"Jekle","year":"2025"},{"key":"10.1016\/j.antiviral.2026.106510_bib19","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/HEP.0000000000000428","article-title":"Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation","volume":"78","author":"Kum","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106510_bib20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00835-18","article-title":"Novel potent capsid assembly modulators regulate multiple steps of the hepatitis B virus life cycle","volume":"62","author":"Lahlali","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib22","article-title":"Preclinical characterization of NVR 3-778, a first-in-class capsid assembly modulator against Hepatitis B virus","volume":"63","author":"Lam","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/cphc.201800211","article-title":"Localizing conformational hinges by NMR: where do hepatitis B virus core proteins adapt for capsid assembly?","volume":"19","author":"Lecoq","year":"2018","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.antiviral.2026.106510_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-023-36219-3","article-title":"Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR","volume":"14","author":"Lecoq","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106510_bib25","series-title":"Capsid Assembly Modulator Dosing Regimen","author":"Lenz","year":"2019"},{"key":"10.1016\/j.antiviral.2026.106510_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2017.05.008","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"67","author":"Lok","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106510_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105211","article-title":"Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein","volume":"197","author":"Mani","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106510_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jvh.12838","article-title":"Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B","volume":"25","author":"Nam","year":"2018","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2026.106510_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-6700-1_2","article-title":"Hepatitis B virus infection of HepaRG cells, HepaRG-hNTCP cells, and primary human hepatocytes","volume":"1540","author":"Ni","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2026.106510_bib30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3390\/biomedicines9111577","article-title":"The hepatitis B virus nucleocapsid-dynamic compartment for infectious virus production and new antiviral target","volume":"9","author":"Niklasch","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.antiviral.2026.106510_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.virol.2010.08.015","article-title":"A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance","volume":"407","author":"Porterfield","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2026.106510_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/microorganisms13010157","article-title":"From the cytoplasm into the Nucleus-Hepatitis B virus travel and genome repair","volume":"13","author":"Ringlander","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.antiviral.2026.106510_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2026.106510_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10858-016-0060-y","article-title":"CcpNmr AnalysisAssign: a flexible platform for integrated NMR analysis","volume":"66","author":"Skinner","year":"2016","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.antiviral.2026.106510_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nbt1187","article-title":"An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly","volume":"24","author":"Stray","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2026.106510_bib36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2006.05.019","article-title":"Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus","volume":"45","author":"Sun","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106510_bib37","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection: a review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2026.106510_bib38","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/jcm11051349","article-title":"Capsid assembly modulators as antiviral agents against HBV: molecular mechanisms and clinical perspectives","volume":"11","author":"Taverniti","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.antiviral.2026.106510_bib39","first-page":"367","article-title":"Review of current and potential treatments for chronic hepatitis B virus infection","volume":"17","author":"Tsai","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106510_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.coviro.2021.10.003","article-title":"Hepatitis B virus e antigen and viral persistence","volume":"51","author":"Tsai","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2026.106510_bib41","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1021\/acs.jmedchem.8b00654","article-title":"Synthesis and evaluation of N-phenyl-3-sulfamoyl-benzamide derivatives as capsid assembly modulators inhibiting hepatitis B virus (HBV)","volume":"61","author":"Vandyck","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106510_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00722-23","article-title":"Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles","volume":"97","author":"Vanrusselt","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106510_bib43","doi-asserted-by":"crossref","first-page":"21126","DOI":"10.1021\/acs.jmedchem.4c01814","article-title":"The discovery and preclinical profile of ALG-000184, a prodrug of the potent hepatitis B virus capsid assembly modulator ALG-001075","volume":"67","author":"Vendeville","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106510_bib44","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.03058-15","article-title":"Hepatitis B virus capsids have diverse structural responses to small-molecule ligands bound to the heteroaryldihydropyrimidine pocket","volume":"90","author":"Venkatakrishnan","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106510_bib45","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/jac\/dkaa179","article-title":"Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro","volume":"75","author":"Verbinnen","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105660","article-title":"Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study","volume":"216","author":"Verbinnen","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106510_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104917","article-title":"Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B","volume":"182","author":"Viswanathan","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106510_bib49","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.01091-13","article-title":"Preclinical characterization of GLS4, an inhibitor of Hepatitis B virus core particle assembly","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106510_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hep.30514","article-title":"Direct inhibition of hepatitis B e antigen by core protein allosteric modulator","volume":"70","author":"Yan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106510_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2026.106510_bib52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2022.04.005","article-title":"Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection","volume":"77","author":"Yuen","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106510_bib53","series-title":"Long-Term Dosing with the Capsid Assembly Modulator ALG-000184 Results in the multi-log Reductions of DNA, RNA, Hbsag, Hbeag and Hbcrag in Untreated Hbeag Positive Chronic Hepatitis B Subjects","author":"Yuen","year":"2023"},{"key":"10.1016\/j.antiviral.2026.106510_bib54","series-title":"Extended Treatment of Hbeag+ CHB Subjects with the Capsid Assembly Modulator ALG-000184 with or Without Entecavir is Associated with Reductions in Viral Markers and Favorable Anti-hbeag Trends","author":"Yuen","year":"2024"},{"key":"10.1016\/j.antiviral.2026.106510_bib55","series-title":"Monotherapy with the Novel Capsid Assembly Modulator ALG-000184 for up to 96 Weeks Results in Profound and Sustained HBV DNA Suppression in Untreated Subjects with Chronic HBV Infection","author":"Yuen","year":"2025"},{"key":"10.1016\/j.antiviral.2026.106510_bib56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(25)00293-6","article-title":"ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial","volume":"11","author":"Yuen","year":"2026","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106510_bib57","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106510_bib58","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/JVI.76.10.4848-4854.2002","article-title":"A small molecule inhibits and misdirects assembly of hepatitis B virus capsids","volume":"76","author":"Zlotnick","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106510_bib59","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-022-00700-z","article-title":"Nomenclature of HBV core protein-targeting antivirals","volume":"19","author":"Zoulim","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:17Z","timestamp":1793036597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":56,"alternative-id":["S0166354226001695"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106510","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral profile of hepatitis B virus capsid assembly modulator ALG-001075, the parent of pevifoscorvir sodium","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106510"}}